288 related articles for article (PubMed ID: 8619526)
1. Glial differentiation predicts poor clinical outcome in primitive neuroectodermal brain tumors.
Janss AJ; Yachnis AT; Silber JH; Trojanowski JQ; Lee VM; Sutton LN; Perilongo G; Rorke LB; Phillips PC
Ann Neurol; 1996 Apr; 39(4):481-9. PubMed ID: 8619526
[TBL] [Abstract][Full Text] [Related]
2. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors.
Molenaar WM; Jansson DS; Gould VE; Rorke LB; Franke WW; Lee VM; Packer RJ; Trojanowski JQ
Lab Invest; 1989 Dec; 61(6):635-43. PubMed ID: 2557487
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ki-67 (MIB-1) proliferation index in childhood primitive neuroectodermal tumors of the central nervous system.
Grotzer MA; Geoerger B; Janss AJ; Zhao H; Rorke LB; Phillips PC
Med Pediatr Oncol; 2001 Feb; 36(2):268-73. PubMed ID: 11452934
[TBL] [Abstract][Full Text] [Related]
4. Neurotrophin receptor TrkC predicts good clinical outcome in medulloblastoma and other primitive neuroectodermal brain tumors.
Grotzer MA; Janss AJ; Phillips PC; Trojanowski JQ
Klin Padiatr; 2000; 212(4):196-9. PubMed ID: 10994550
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
6. Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice.
Fung KM; Chikaraishi DM; Suri C; Theuring F; Messing A; Albert DM; Lee VM; Trojanowski JQ
Lab Invest; 1994 Jan; 70(1):114-24. PubMed ID: 7508007
[TBL] [Abstract][Full Text] [Related]
7. Patterns of treatment failure in infants with primitive neuroectodermal tumors who were treated on CCG-921: a phase III combined modality study.
Hong TS; Mehta MP; Boyett JM; Donahue B; Rorke LB; Zeltzer PM
Pediatr Blood Cancer; 2005 Oct; 45(5):676-82. PubMed ID: 16007595
[TBL] [Abstract][Full Text] [Related]
8. [Glial fibrillary acidic protein and neurofilament protein in medulloblastoma].
Tohyama T; Kubo O; Katahira M; Sakairi M; Tajika T; Tajika Y; Kitamura K
No Shinkei Geka; 1988 Oct; 16(11):1243-50. PubMed ID: 3145467
[TBL] [Abstract][Full Text] [Related]
9. Chlorotoxin, a scorpion-derived peptide, specifically binds to gliomas and tumors of neuroectodermal origin.
Lyons SA; O'Neal J; Sontheimer H
Glia; 2002 Aug; 39(2):162-73. PubMed ID: 12112367
[TBL] [Abstract][Full Text] [Related]
10. Supratentorial primitive neuroectodermal tumours of the brain: multidirectional differentiation does not influence prognosis. A clinicopathological report of 18 patients.
Visée S; Soltner C; Rialland X; Machet MC; Loussouarn D; Milinkevitch S; Pasco-Papon A; Mercier P; Rousselet MC
Histopathology; 2005 Apr; 46(4):403-12. PubMed ID: 15810952
[TBL] [Abstract][Full Text] [Related]
11. Apurinic/apyrimidinic endonuclease activity is associated with response to radiation and chemotherapy in medulloblastoma and primitive neuroectodermal tumors.
Bobola MS; Finn LS; Ellenbogen RG; Geyer JR; Berger MS; Braga JM; Meade EH; Gross ME; Silber JR
Clin Cancer Res; 2005 Oct; 11(20):7405-14. PubMed ID: 16243814
[TBL] [Abstract][Full Text] [Related]
12. MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma.
Grotzer MA; Hogarty MD; Janss AJ; Liu X; Zhao H; Eggert A; Sutton LN; Rorke LB; Brodeur GM; Phillips PC
Clin Cancer Res; 2001 Aug; 7(8):2425-33. PubMed ID: 11489822
[TBL] [Abstract][Full Text] [Related]
13. High microvessel density in primitive neuroectodermal brain tumors of childhood.
Grotzer MA; Wiewrodt R; Janss AJ; Zhao H; Cnaan A; Sutton LN; Rorke LB; Phillips PC
Neuropediatrics; 2001 Apr; 32(2):75-9. PubMed ID: 11414647
[TBL] [Abstract][Full Text] [Related]
14. Coexpression of platelet-derived growth factor alpha and beta receptors on medulloblastomas and other primitive neuroectodermal tumors is consistent with an immature stem cell and neuronal derivation.
Smits A; van Grieken D; Hartman M; Lendahl U; Funa K; Nistér M
Lab Invest; 1996 Jan; 74(1):188-98. PubMed ID: 8569181
[TBL] [Abstract][Full Text] [Related]
15. Central neurocytomas express photoreceptor differentiation.
Mena H; Morrison AL; Jones RV; Gyure KA
Cancer; 2001 Jan; 91(1):136-43. PubMed ID: 11148570
[TBL] [Abstract][Full Text] [Related]
16. Primitive neuroectodermal tumors including the medulloblastoma: glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ("arachnoidal sarcoma of the cerebellum").
Herpers MJ; Budka H
Clin Neuropathol; 1985; 4(1):12-8. PubMed ID: 3978900
[TBL] [Abstract][Full Text] [Related]
17. Sox2 expression in brain tumors: a reflection of the neuroglial differentiation pathway.
Phi JH; Park SH; Kim SK; Paek SH; Kim JH; Lee YJ; Cho BK; Park CK; Lee DH; Wang KC
Am J Surg Pathol; 2008 Jan; 32(1):103-12. PubMed ID: 18162777
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological analysis of nine consecutive central nervous system primitive neuroectodermal tumors in a single institute.
Aizawa-Kohama M; Kumabe T; Saito R; Kanamori M; Yamashita Y; Sonoda Y; Watanabe M; Tominaga T
Brain Tumor Pathol; 2013 Jan; 30(1):15-27. PubMed ID: 22434332
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical analysis of medulloblastoma and PNET with emphasis on N-myc protein expression.
Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
Anticancer Res; 1996; 16(5A):2687-92. PubMed ID: 8917371
[TBL] [Abstract][Full Text] [Related]
20. Primitive neuroectodermal tumors of the cerebrum: a histological and immunohistochemical study of 10 cases.
Grant JW; Steart PV; Gallagher PJ
Clin Neuropathol; 1988; 7(5):228-33. PubMed ID: 2850125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
